Subsequently, we developed a PRPS2-specific antibody capable of distinguishing PRPS2 from PRPS1 (Supplementary Fig. 2) and assessed PRPS2 protein expression levels in 12 pairs of randomly selected lung adenocarcinoma specimens (indicated by black arrows in Fig. 1b). This evidence concerns the gene PRPS2 and lung adenocarcinoma.